Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Shares Outstanding (2016 - 2025)

Ptc Therapeutics has reported Shares Outstanding over the past 14 years, most recently at $81.5 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $81.5 million for Q4 2025, up 4.85% from a year ago — trailing twelve months through Dec 2025 was $81.5 million (up 4.85% YoY), and the annual figure for FY2025 was $81.5 million, up 4.85%.
  • Shares Outstanding for Q4 2025 was $81.5 million at Ptc Therapeutics, up from $79.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding for PTCT hit a ceiling of $81.5 million in Q4 2025 and a floor of $70.4 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $75.4 million (2023), compared with a mean of $74.9 million.
  • Biggest five-year swings in Shares Outstanding: grew 12.19% in 2021 and later increased 1.32% in 2022.
  • Ptc Therapeutics' Shares Outstanding stood at $70.8 million in 2021, then grew by 3.21% to $73.1 million in 2022, then grew by 3.56% to $75.7 million in 2023, then increased by 2.64% to $77.7 million in 2024, then rose by 4.85% to $81.5 million in 2025.
  • The last three reported values for Shares Outstanding were $81.5 million (Q4 2025), $79.9 million (Q3 2025), and $79.4 million (Q2 2025) per Business Quant data.